Trials / Completed
CompletedNCT05250817
A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 501 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational study is to determine participants' preferences for outcomes associated with first-line treatment of advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) using a discrete-choice experiment (DCE).
Conditions
Timeline
- Start date
- 2021-12-09
- Primary completion
- 2023-01-04
- Completion
- 2023-01-04
- First posted
- 2022-02-22
- Last updated
- 2023-06-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05250817. Inclusion in this directory is not an endorsement.